Atlas Trials

Two-Stage Study to Assess the Efficacy and Safety of 12 Weeks of Treatment With PEP03 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Clinical trial NCT00219648 · UNKNOWN

Trial details

NCT number
NCT00219648
Sponsor
PharmaEngine
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
COPD
Start date
2004-09-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.